← Leaderboards
Artour Gomtsian
Synventa, Llc
$499,665
Attributed
$499,665
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $277.4K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$499,665 · 2
By mechanism
R43$499,665 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Non-Opioid Analgesic”
- Cecile Feldman · Rbhs-School Of Dental Medicine$11,278,781
- Bryan L McLaughlin · Micro-Leads, Inc.$10,201,646
- James N Campbell · Centrexion Therapeutics Corporation$8,662,635
- Christian Arthur Heidbreder · Indivior, Inc.$8,483,680
- James Jeffrey Sahn · 4e Therapeutics Inc.$7,126,294
- Kristen Leann Gullo · Us Worldmeds, Llc$5,806,657
Research focus
Non-Opioid AnalgesicClinical DevelopmentPropertyPharmaceutical PreparationsDoseExperimental StudyHypotensionPre-ClinicalSmall Business Innovation Research GrantAnalgesicsBiologicalBenefits And RisksBlood PressureBody TemperatureAgonistAdrenergic ReceptorBaseClinical PracticeBackAdverse EffectsClonidineCombatConsciousChronic Pain